Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.45 USD
6.89 B USD
52.94 B USD
1.47 B
About ASTRAZENECA PLC ORD USD0.25
Sector
CEO
Pascal Soriot
Headquarters
Cambridge
Website
Founded
1992
ISIN
GB0009895292
FIGI
BBG000D3NTM5
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where AZNCF is featured.
Frequently Asked Questions
The current price of AZNCF is 144.25 USD — it has decreased by −2.11% in the past 24 hours. Watch AstraZeneca Plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange AstraZeneca Plc stocks are traded under the ticker AZNCF.
AZNCF stock has fallen by −0.39% compared to the previous week, the month change is a 8.42% rise, over the last year AstraZeneca Plc has showed a 13.25% increase.
We've gathered analysts' opinions on AstraZeneca Plc future price: according to them, AZNCF price has a max estimate of 239.22 USD and a min estimate of 136.27 USD. Watch AZNCF chart and read a more detailed AstraZeneca Plc stock forecast: see what analysts think of AstraZeneca Plc and suggest that you do with its stocks.
AZNCF reached its all-time high on Aug 30, 2024 with the price of 175.00 USD, and its all-time low was 30.20 USD and was reached on Mar 5, 2009. View more price dynamics on AZNCF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AZNCF stock is 3.99% volatile and has beta coefficient of 1.12. Track AstraZeneca Plc stock price on the chart and check out the list of the most volatile stocks — is AstraZeneca Plc there?
Today AstraZeneca Plc has the market capitalization of 228.34 B, it has increased by 3.97% over the last week.
Yes, you can track AstraZeneca Plc financials in yearly and quarterly reports right on TradingView.
AstraZeneca Plc is going to release the next earnings report on Apr 29, 2025. Keep track of upcoming events with our Earnings Calendar.
AZNCF earnings for the last quarter are 2.09 USD per share, whereas the estimation was 2.07 USD resulting in a 0.96% surprise. The estimated earnings for the next quarter are 2.21 USD per share. See more details about AstraZeneca Plc earnings.
AstraZeneca Plc revenue for the last quarter amounts to 14.89 B USD, despite the estimated figure of 14.23 B USD. In the next quarter, revenue is expected to reach 13.73 B USD.
AZNCF net income for the last quarter is 1.46 B USD, while the quarter before that showed 1.47 B USD of net income which accounts for −0.38% change. Track more AstraZeneca Plc financial stats to get the full picture.
As of Feb 20, 2025, the company has 94.30 K employees. See our rating of the largest employees — is AstraZeneca Plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AstraZeneca Plc EBITDA is 17.22 B USD, and current EBITDA margin is 33.02%. See more stats in AstraZeneca Plc financial statements.
Like other stocks, AZNCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AstraZeneca Plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AstraZeneca Plc technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AstraZeneca Plc stock shows the buy signal. See more of AstraZeneca Plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.